Cargando…
Oncology Drug Repurposing for Sepsis Treatment
Sepsis involves life-threatening organ dysfunction caused by a dysregulated host response to infection. Despite three decades of efforts and multiple clinical trials, no treatment, except antibiotics and supportive care, has been approved for this devastating syndrome. Simultaneously, numerous precl...
Autores principales: | Rumienczyk, Izabela, Kulecka, Maria, Statkiewicz, Małgorzata, Ostrowski, Jerzy, Mikula, Michal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030585/ https://www.ncbi.nlm.nih.gov/pubmed/35453671 http://dx.doi.org/10.3390/biomedicines10040921 |
Ejemplares similares
-
Multi-Organ Transcriptome Dynamics in a Mouse Model of Cecal Ligation and Puncture-Induced Polymicrobial Sepsis
por: Rumienczyk, Izabela, et al.
Publicado: (2021) -
Selective Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibition by the SCH772984 Compound Attenuates In Vitro and In Vivo Inflammatory Responses and Prolongs Survival in Murine Sepsis Models
por: Kopczynski, Michal, et al.
Publicado: (2021) -
Cytotoxic Efficacy and Resistance Mechanism of a TRAIL and VEGFA-Peptide Fusion Protein in Colorectal Cancer Models
por: Kopczynski, Michal, et al.
Publicado: (2021) -
Beads-free protein immunoprecipitation for a mass spectrometry-based interactome and posttranslational modifications analysis
por: Mikula, Michal, et al.
Publicado: (2015) -
High Prevalence of Genetically Related Clostridium Difficile Strains at a Single Hemato-Oncology Ward Over 10 Years
por: Waker, Edyta, et al.
Publicado: (2020)